Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy target.

Although an upward trend in IFN‐γ secretion by tumor‐infiltrating immune cells (TIICs) was observed after M‐siC9ORF50‐2 treatment, the difference did not reach statistical significance ( p = 0.17) (Figure S13D ).

also in 111,027 other papers